Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008


  Biliary Tract Diseases

  Free Subscription


Articles published in J Hepatol

Retrieve available abstracts of 51 articles:
HTML format



Single Articles


    May 2008
  1. BLECHACZ B , Gores GJ
    Tumor-specific marker genes for intrahepatic cholangiocarcinoma: Utility and mechanistic insight.
    J Hepatol. 2008;.
    PubMed     Related articles   


  2. USECHAK P , Gates A, Webster CR
    Activation of focal adhesion kinase and JNK contributes to the extracellular matrix and cAMP-GEF mediated survival from bile acid induced apoptosis in rat hepatocytes.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available


  3. NISHINO R , Honda M, Yamashita T, Takatori H, et al
    Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available


    March 2008
  4. CARD TR , Solaymani-Dodaran M, West J
    Incidence and mortality of primary sclerosing cholangitis in the UK: A population-based cohort study.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available


  5. YANG YY , Lee KC, Huang YT, Wang YW, et al
    Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available


    February 2008
  6. CULLEN SN , Rust C, Fleming K, Edwards C, et al
    High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available


  7. SILVEIRA MG , Lindor KD
    High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
    J Hepatol. 2008;.
    PubMed     Related articles   


  8. WEISMULLER TJ , Wedemeyer J, Kubicka S, Strassburg CP, et al
    The challenges in primary sclerosing cholangitis - Aetiopathogenesis, autoimmunity, management and malignancy.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available


  9. LAMMERT F , Miquel JF
    Gallstone disease: From genes to evidence-based therapy.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available


    January 2008
  10. POPOV Y , Patsenker E, Stickel F, Zaks J, et al
    Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available


  11. SAID K , Glaumann H, Bergquist A
    Gallbladder disease in patients with primary sclerosing cholangitis.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available


    December 2007
  12. DEMETRIS AJ , Specht S, Nozaki I, Lunz JG 3rd, et al
    Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available


  13. SCHOLTES C , Diaz O, Icard V, Kaul A, et al
    Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available


    October 2007
  14. SOOKOIAN S , Castano G, Burgueno A, Gianotti TF, et al
    Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available


  15. KOVACS P , Kress R, Rocha J, Kurtz U, et al
    Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available


    July 2007
  16. GORES GJ , Nagorney DM, Rosen CB
    Cholangiocarcinoma: Is transplantation an option? For whom?
    J Hepatol. 2007;.
    PubMed     Related articles   


  17. GROEN A , Kunne C, Paulusma CC, Kramer W, et al
    Intestinal bile salt absorption in Atp8b1 deficient mice.
    J Hepatol. 2007;47:114-22.
    PubMed     Related articles    Abstract available


    June 2007
  18. LEMPINEN M , Isoniemi H, Makisalo H, Nordin A, et al
    Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available


  19. JANSEN PL
    Endogenous bile acids as carcinogens.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available


  20. JONES DE
    Fatigue in cholestatic liver disease: is it all in the mind?
    J Hepatol. 2007;46:992-4.
    PubMed     Related articles   


    May 2007
  21. ZALINSKI S , Paradis V, Valla D, Belghiti J, et al
    Intraductal papillary mucinous tumors of both biliary and pancreatic ducts.
    J Hepatol. 2007;46:978-9.
    PubMed     Related articles   


  22. KARLSEN TH , Boberg KM, Olsson M, Sun JY, et al
    Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.
    J Hepatol. 2007;46:899-906.
    PubMed     Related articles    Abstract available


    April 2007
  23. WARD SM , Fox BC, Brown PJ, Worthington J, et al
    Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available


  24. HONDA Y , Yamagiwa S, Matsuda Y, Takamura M, et al
    Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available


  25. HERATH CB , Warner FJ, Lubel JS, Dean RG, et al
    Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis>
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available


  26. GLUUD C , Brok J, Gong Y, Koretz RL, et al
    Hepatology may have problems with putative surrogate outcome measures.
    J Hepatol. 2007;46:734-42.
    PubMed     Related articles    Abstract available


  27. MARZIONI M , Svegliati Baroni G, Alpini G, Benedetti A, et al
    Endogenous opioid peptides and chronic liver disease: from bedside to bench.
    J Hepatol. 2007;46:583-6.
    PubMed     Related articles   


    March 2007
  28. VAN OS E , van den Broek WW, Mulder PG, Ter Borg PC, et al
    Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available


  29. GARCIA-TSAO G
    Liver involvement in hereditary hemorrhagic telangiectasia (HHT).
    J Hepatol. 2007;46:499-507.
    PubMed     Related articles    Abstract available


    January 2007
  30. LAERM A , Helmbold P, Goldberg M, Dammann R, et al
    Prospero-related homeobox 1 (PROX1) is frequently inactivated by genomic deletions and epigenetic silencing in carcinomas of the bilary system.
    J Hepatol. 2007;46:89-97.
    PubMed     Related articles    Abstract available


    December 2006
  31. HOUTEN SM
    A liver revival featuring bile acids.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


  32. BOYER JL
    New perspectives for the treatment of cholestasis: Lessons from basic science applied clinically.
    J Hepatol. 2006;.
    PubMed     Related articles   


    November 2006
  33. WAHLIN S , Aschan J, Bjornstedt M, Broome U, et al
    Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasis.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


  34. ELFERINK RO
    "Return to sender, address unknown...." Are variant addressins involved in PSC?
    J Hepatol. 2006;45:633-5.
    PubMed     Related articles   


    October 2006
  35. NAUS PJ , Henson R, Bleeker G, Wehbe H, et al
    Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


    September 2006
  36. MALHI H , Gores GJ
    Cholangiocarcinoma: Modern advances in understanding a deadly old disease.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


  37. PUSL T , Denk GU, Parhofer KG, Beuers U, et al
    Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


    August 2006
  38. KULAKSIZ H , Rudolph G, Kloeters-Plachky P, Sauer P, et al
    Biliary candida infections in primary sclerosing cholangitis.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


    July 2006
  39. KORNER M , Hayes GM, Rehmann R, Zimmermann A, et al
    Secretin receptors in the human liver: Expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


  40. BASKIN-BEY ES , Moreno Luna LE, Gores GJ
    Diagnosis of cholangiocarcinoma in patients with PSC: A sight on cytology.
    J Hepatol. 2006;.
    PubMed     Related articles   


    June 2006
  41. BOBERG KM , Jebsen P, Clausen OP, Foss A, et al
    Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


  42. GROEN AK
    The emerging role of bile acids as integrators of intermediary metabolism.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


    May 2006
  43. GOUW AS , van den Heuvel MC, Boot M, Slooff MJ, et al
    Dynamics of the vascular profile of the finer branches of the biliary tree in normal and diseased human livers.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


    April 2006
  44. BOWLUS CL , Karlsen TH, Broome U, Thorsby E, et al
    Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


  45. PETROWSKY H , Wildbrett P, Husarik DB, Hany TF, et al
    Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


  46. CARIOU B , Staels B
    The expanding role of the bile acid receptor FXR in the small intestine.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


  47. BIHL F , Emmenegger U, Reichen J, Neftel KA, et al
    Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


  48. TUTTLE-NEWHALL JE , Diehl AM
    What impact does a specialized center for transplantation and heptobiliary disease have on post-graduate resident training of gastroenterologists and surgeons?
    J Hepatol. 2006;44:659-62.
    PubMed     Related articles   


    February 2006
  49. BERGQUIST A , Glaumann H, Lindberg B, Broome U, et al
    Primary sclerosing cholangitis can present with acute liver failure: Report of two cases.
    J Hepatol. 2006;.
    PubMed     Related articles    Abstract available


    January 2006
  50. LAM CW , Cheung KM, Tsui MS, Yan MS, et al
    A patient with novel ABCB11 gene mutations with phenotypic transition between BRIC2 and PFIC2.
    J Hepatol. 2006;44:240-2.
    PubMed     Related articles    Abstract available


    May 2005
  51. FROSSARD JL
    Conversion of biliary system to pancreatic tissue: complete plasticity or same organ?
    J Hepatol. 2005;42:782-3.
    PubMed     Related articles   


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: